Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to access life-changing weight loss medications.

HealthDay News — For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study ...

Despite the compact interior, this custom camper van has a kitchen, a cozy bedroom, and a garage offering abundant storage space.

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like Ozempic.

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...

A man from El Paso, Texas, is on a mission to move and fully refurbish a derelict 59-year-old Boeing 727 that he and his brother bought for $10,000. When the massive project is finished, 40-year ...

You may like This simple DIY air conditioner helped me fall asleep fast during a heatwave — here's how to try it I thought this viral cooling fan hack was crazy — but it actually works I made ...

BrightGene is pitting BGM0504 against tirzepatide, the rival GLP-1/GIP drug in Lilly’s Mounjaro and Zepbound, in a phase 2 obesity trial that is scheduled to wrap up next year.

The average American consumes only half the recommended fiber intake, contributing to health problems, but simple breakfast swaps like berries over bananas can boost fiber consumption.

People with obesity and prediabetes assigned tirzepatide were more likely to have sustained weight loss than those assigned placebo. Most people on tirzepatide sustained weight loss through 176 weeks.